Jim Cramer on Bank of America: “It’s a Very Inexpensive Stock”
Bank of America Corporation (NYSE:BAC) is one of the stocks Jim Cramer had in this week’s game plan.
Insider Monkey Blog
Jim Cramer on Robinhood: “I’m Betting We Get Some Fantastic Numbers”
“Robinhood reports after the close, and this online brokerage has managed to win over millions of investors, maybe you.
Jim Cramer Says “Caterpillar’s Become One of the Best Performers in the Entire Market”
“Caterpillar’s become one of the best performers in the entire market, and I think that move is justified given how so much of their equipment is used to make and maintain...
Jim Cramer Says Axon is One of the “Long-Term Outperformers That You Simply Have to Consider Owning”
“After the close, we have two huge winners so far this year, well, one for many, many years, well, actually both of them really, AMD and Axon.
Jim Cramer on Uber: “Another Company That’s Fulfilling Its Grand Ambitions”
Uber Technologies, Inc. (NYSE:UBER) is one of the stocks Jim Cramer had in this week’s game plan. Cramer showed optimism toward the company’s stock doing well.
Jim Cramer on Shopify: “It’s Become a Very Reliable Winner”
“Shopify turns in its numbers, too. This is a good one, Canadian, terrific. This, it’s become a very reliable winner. I think it can duplicate.
Jim Cramer on Pfizer: “We’ll Find Out if Pfizer’s Going to Be More of a Stock and Less of a Bond Equivalent”
“Now, will Pfizer break out from the $25 level? Oh, it’s been a dull run for this former growth drug stock as shareholders seem to be satisfied with a 7% yield, not much price...
Jim Cramer Says “Clorox is at the Heart of This Market’s Conundrum”
“Now, we also hear from Clorox, quite different from Palantir, with a stock that is down more than 30% for the year. Clorox is at the heart of this market’s conundrum.
Jim Cramer on Palantir: “I’m Not Backing Away From This One Long Term”
Palantir Technologies Inc. (NASDAQ:PLTR) is one of the stocks Jim Cramer had in this week’s game plan.
Jim Cramer on Berkshire: “You Have to Expect More Profit Taking as Buffett Leaves”
“Let’s see what the first week of November has in store for us. Now, we don’t have to wait until Monday for some important news.
Jim Cramer Says “Lisa Su at AMD is Challenging Nvidia at Its Own Game”
Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the stocks Jim Cramer had in this week’s game plan.
Jim Cramer Believes McDonald’s Can Tell “If the People Decided That Tastes Have Changed”
McDonald’s Corporation (NYSE:MCD) is one of the stocks Jim Cramer had in this week’s game plan.
Buy Dexscreener Rockets & Reactions – Boost Legends!
If your token is new—or you’re trying to recover momentum—visibility on DexScreener determines whether buyers discover you or scroll past.
Baron Health Care Fund Repurchased UnitedHealth Group Incorporated (UNH) in Q3. Here’s Why
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why Baron Health Care Fund Added Thermo Fisher Scientific (TMO) to Its Portfolio
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s What Drove Baron Health Care Fund to Add AbbVie (ABBV) to Its Portfolio
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Approval of Brinsupri Lifted Insmed Incorporated (INSM) in Q3
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
argenx SE (ARGX) Rose due to Increased Sales of its Vyvgart Medication
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Baron Health Care Fund’s Q3 2025 Investor Letter
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter.
Analyst Says NVIDIA (NVDA) Price/Sales Ratio is a ‘Big Number’ – ‘We Shall See’
Guy Adami from CNBC recently commented on NVIDIA Corp (NASDAQ:NVDA) announcement that the company expects $500 billion in GPU sales between the Blackwell generation and next year...
Josh Brown Highlights The ‘Biggest Open Question’ About Apple (AAPL) AI Strategy
Josh Brown from CNBC recently commented on the impact of the Microsoft-OpenAI deal on Apple.
From Generation Z to Baby Boomers: Why Every Generation Now Wants a Piece of Crypto
Not too long ago, crypto was seen as a sideshow. It was something for the tech crowd and the early adopters. Fast forward several years, and the story has completely changed.
NVIDIA Corporation (NVDA): Uniquely Positioned at the Center of the Global AI Computing Cycle
Columbia Threadneedle Investments, an investment management company, released its “Columbia Global Technology Growth Fund” third-quarter 2025 investor letter.
What Makes Robinhood (HOOD) a Good Investment?
Columbia Threadneedle Investments, an investment management company, released its “Columbia Global Technology Growth Fund” third-quarter 2025 investor letter.
Exceptional Results and Investor Enthusiasm Lifted Astera Labs (ALAB)
Columbia Threadneedle Investments, an investment management company, released its “Columbia Global Technology Growth Fund” third-quarter 2025 investor letter.
Here’s What Impacted ServiceNow (NOW) in Q3
Columbia Threadneedle Investments, an investment management company, released its “Columbia Global Technology Growth Fund” third-quarter 2025 investor letter.
Salesforce (CRM) Declined Following the Guidance
Columbia Threadneedle Investments, an investment management company, released its “Columbia Global Technology Growth Fund” third-quarter 2025 investor letter.
Accenture (ACN) Fell in Q3 Amid Strong Growth Trajectories
Columbia Threadneedle Investments, an investment management company, released its “Columbia Global Technology Growth Fund” third-quarter 2025 investor letter.
The Trade Desk (TTD) Slipped on Cautious Guidance
Columbia Threadneedle Investments, an investment management company, released its “Columbia Global Technology Growth Fund” third-quarter 2025 investor letter.
Broadcom (AVGO) Surged on Exceptional Demand for AI Chips
Columbia Threadneedle Investments, an investment management company, released its “Columbia Global Technology Growth Fund” third-quarter 2025 investor letter.
Columbia Global Technology Growth Fund’s Q3 2025 Investor Letter
Columbia Threadneedle Investments, an investment management company, released its “Columbia Global Technology Growth Fund” third-quarter 2025 investor letter.
Analyst on AbbVie (ABBV): ‘Stay Long’
Jason Snipe, the Founder and Chief Investment Officer of Odyssey Capital Advisors, recommended investors to “stay long” AbbVie Inc (NYSE:ABBV) during a recent program on CNBC...
Analyst Says She’s ‘Suspicious’ About ‘Sustainability’ of Apple (AAPL) Stock Uptrend – Here’s Why
Katie Stockton, Fairlead Strategies founder and managing partner, commented on Apple’s latest stock outperformance during a program on CNBC.
The “Lost Decade” Myth: How to Find Growth When Markets Go Nowhere
With whispers of high valuations, extreme market concentration, and slowing growth, the fear of a new “lost decade” is palpable among investors.
Here’s What Supports Essential Utilities’ (WTRG) Stability and Dividend Growth?
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter.
MACOM Technology Solutions (MTSI) Fell Despite Reporting Strong Results
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter.
Should You Hold Haemonetics Corporation (HAE)?
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter.
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q3 2025 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to the Kiniksa Pharmaceuticals Third Quarter 2025 Earnings Conference Call.
Is Advanced Micro Devices (AMD) The Best Semiconductor Stock to Benefit from AI Bull Run Until 2030?
Vivek Arya, semiconductor analyst at Bank of America, said in a recent interview with CNBC that the current bull market for AI semiconductor companies could go for a couple of...
Here’s Why Alamos Gold (AGI) Surged in Q3
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter.
Should You Consider Adding Hilton Grand Vacations (HGV) to Your Portfolio?
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter.
Here’s How the Acquisition Favored James Hardie Industries (JHX)
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter.
Should You Invest in Pinnacle West Capital (PNW)?
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter.
Primo Brands (PRMB) Positioned to Capitalize on Surging Bottled Water Consumption
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter.
Service Corporation International (SCI) is Leveraging Aging Population Trends
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter.
12 Best Performing Stocks in the Last 3 Months
On Friday, October 31, shares of tech giant Amazon.com, Inc. (AMZN) boosted the market after it reported strong quarterly earnings. The tech-heavy Nasdaq increased by 0.61%.
Analyst Says Microsoft (MSFT) at ‘Intersection’ of Software and AI
Richard Saperstein from Treasury Partners said in a recent program on CNBC before Microsoft's latest earnings report that he believed the company would be able to achieve mid-...
Why These Energy Stocks are Gaining This Week
The American nuclear energy sector was among the biggest winners this week after the US government signed a deal to invest over $80 billion to build nuclear reactors across the...
Is Lexeo Therapeutics (LXEO) One of Billionaire Daniel Sundheim’s Stock Picks with Huge Upside Potential
Lexeo Therapeutics (NASDAQ:LXEO) is one of billionaire Daniel Sundheim’s stock picks with huge upside potential.
Affirm Holdings, Inc. (AFRM) Deepens Ties with New York Life in $750M Loan Deal
Affirm Holdings, Inc. (NASDAQ:AFRM) is one of billionaire Daniel Sundheim’s stock picks with huge upside potential. On October 31, Affirm Holdings, Inc.
Hedge Fund Resource Center
